Physician profile
Randall E Schrager
NPI 1922058072
$15,213.62
in general payments reported to CMS, 2019-2025
16 companies · $55.08 in 2025
The $55.08 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,682 · 2020: $8,670 · 2021: $3,034 · 2022: $643 · 2023: $130 · 2025: $55.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,652.56 | 2019-2023 | Da Vinci Surgical System |
| Organogenesis INC. | $116.93 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Baxter Healthcare | $77.19 | 2019 | |
| Allergan, INC. | $60.93 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $41.50 | 2020 | |
| W. L. Gore & Associates, INC. | $40.11 | 2022 | |
| Idorsia Pharmaceuticals US INC | $35.00 | 2023 | Quviviq |
| Avanos Medical | $34.59 | 2019 | |
| Abbott Laboratories | $33.51 | 2019-2020 | |
| Ethicon US, LLC | $25.57 | 2019-2022 | |
| Davol INC. | $19.36 | 2020 | |
| Elucent Medical | $19.17 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $17.26 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.27 | 2022 | |
| Covidien Lp | $12.55 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Schrager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.